Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

OmniAb Revenue Rises to $4.0 Million as 2026 Outlook Increases

None

OmniAb (OABI) reported third-quarter 2026 revenue of $4.0 million, up from $2.2 million a year earlier. The company recorded a net loss of $15.7 million, or $0.12 per basic and diluted share, compared with a $16.5 million loss, or $0.14 per share, in the prior-year quarter.

OmniAb raised its full-year 2026 revenue outlook to $35 million to $39 million from $32 million to $36 million. Cash, cash equivalents and short-term investments totaled $64.2 million as of September 30, 2026.

  • Third-quarter total revenue was $3.993 million, including $2.835 million in service revenue and $703,000 in xPloration revenue.
  • Nine-month revenue totaled $31.835 million, versus $10.290 million in the prior-year period.
  • OmniAb expects 2026 costs and operating expenses of $83 million to $87 million.
  • The company expects year-end cash and cash equivalents of $53 million to $57 million, up from its prior outlook of $49 million to $53 million.
  • OmniAb had 111 active partners and 433 active programs as of September 30, including 34 clinical and commercial OmniAb-derived programs.

$OABIW Hedge Fund Activity

We have seen 2 institutional investors add shares of $OABIW stock to their portfolio, and 1 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles